Last reviewed · How we verify
Purified Cortophin Gel, 40 U
Purified Cortophin Gel, 40 U is a ACTH analog / corticotropin Small molecule drug developed by Massachusetts General Hospital. It is currently FDA-approved for Infantile spasms (West syndrome), Multiple sclerosis relapse, Acute exacerbations of autoimmune and inflammatory conditions.
Purified Cortophin Gel is a repository formulation of adrenocorticotropic hormone (ACTH) that stimulates the adrenal cortex to produce and release corticosteroids.
Purified Cortophin Gel is a repository formulation of adrenocorticotropic hormone (ACTH) that stimulates the adrenal cortex to produce and release corticosteroids. Used for Infantile spasms (West syndrome), Multiple sclerosis relapse, Acute exacerbations of autoimmune and inflammatory conditions.
At a glance
| Generic name | Purified Cortophin Gel, 40 U |
|---|---|
| Sponsor | Massachusetts General Hospital |
| Drug class | ACTH analog / corticotropin |
| Target | Melanocortin-2 receptor (MC2R) |
| Modality | Small molecule |
| Therapeutic area | Immunology / Rheumatology / Neurology |
| Phase | FDA-approved |
Mechanism of action
ACTH binds to melanocortin-2 receptors on adrenocortical cells, triggering the synthesis and secretion of endogenous glucocorticoids and mineralocorticoids. The gel formulation provides sustained, depot-like release of ACTH, allowing for prolonged stimulation of adrenal hormone production. This endogenous steroid production can provide anti-inflammatory and immunosuppressive effects in various conditions.
Approved indications
- Infantile spasms (West syndrome)
- Multiple sclerosis relapse
- Acute exacerbations of autoimmune and inflammatory conditions
Common side effects
- Hypertension
- Hypokalemia
- Hyperglycemia
- Mood changes / psychiatric effects
- Insomnia
- Increased infection risk
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Purified Cortophin Gel, 40 U CI brief — competitive landscape report
- Purified Cortophin Gel, 40 U updates RSS · CI watch RSS
- Massachusetts General Hospital portfolio CI
Frequently asked questions about Purified Cortophin Gel, 40 U
What is Purified Cortophin Gel, 40 U?
How does Purified Cortophin Gel, 40 U work?
What is Purified Cortophin Gel, 40 U used for?
Who makes Purified Cortophin Gel, 40 U?
What drug class is Purified Cortophin Gel, 40 U in?
What development phase is Purified Cortophin Gel, 40 U in?
What are the side effects of Purified Cortophin Gel, 40 U?
What does Purified Cortophin Gel, 40 U target?
Related
- Drug class: All ACTH analog / corticotropin drugs
- Target: All drugs targeting Melanocortin-2 receptor (MC2R)
- Manufacturer: Massachusetts General Hospital — full pipeline
- Therapeutic area: All drugs in Immunology / Rheumatology / Neurology
- Indication: Drugs for Infantile spasms (West syndrome)
- Indication: Drugs for Multiple sclerosis relapse
- Indication: Drugs for Acute exacerbations of autoimmune and inflammatory conditions